To evaluate the in vivo antitumor activity of Ad-hLF, the U14 cells were i.t. injected with Ad-hLF (1×109 pfu) or Ad-GFP (1×109 pfu) into tumor-bearing mice, once every other day as described. The gene discussed is HLF; the disease is neoplasm.